Susquehanna International Group’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$994K Buy
+172,200
New +$874K ﹤0.01% 8219

Other funds holding SOPH

Susquehanna International Group's SOPH Position: Q2 2026 in Review

Susquehanna International Group sold out of SOPHiA GENETICS (SOPH) in Q2 2026, closing a stake of 13,156 shares — an estimated $66.8K sold.

Susquehanna International Group first reported a position in SOPH in Q4 2024 and held it in 4 quarters. The position peaked at $142K in Q4 2025. 68 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Susquehanna International Group reported no remaining SOPHiA GENETICS position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 13,156 SOPHiA GENETICS shares in Q2 2026, an estimated $66.8K.
  • Susquehanna International Group first reported a position in SOPHiA GENETICS in Q4 2024 and held it in 4 quarters.
  • Susquehanna International Group's SOPHiA GENETICS position peaked at $142K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.